View the full presentation from our 2022 virtual R&D Day here
to develop effective and safe treatments for cancer
At Candel Therapeutics, our team is developing viral immunotherapies that light up and empower the immune system to fight cancer
Our viral-based approaches allow us to calibrate our immunotherapy treatments to each cancer that we target
Our viral immunotherapies are being designed to have favorable benefit-to-risk profiles, in an effort to ensure patients have efficacious and safe treatments across disease stages
